Literature DB >> 9600823

Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer.

G Baiocchi1, G Grosso, E di Re, R Fontanelli, F Raspagliesi, F di Re.   

Abstract

A retrospective review of the medical records of all ovarian cancer patients admitted to our institution from January 1974 to December 1993 was performed. A total of 58 consecutive patients who underwent systematic pelvic and paraaortic lymphadenectomy during second-look surgery was found. Node metastases were found in 15 of 58 patients (25.8%). No significant correlation was found between the variables of disease (e.g., stage of the disease at diagnosis, histology, grade, residual tumor after the first cytoreductive surgery, and the type of chemotherapy administered) and node status at second-look. Node metastases were found in 8 of 45 (17.7%) patients with absence of intraperitoneal disease, compared with 7 of 11 (63.6%) patients with intraabdominal residual disease (P < 0.02). There was no difference in 5-year survival for patients with absence of residual tumor in the peritoneal cavity as well as in the retroperitoneum (5-year survival 80%) and for patients with retroperitoneal disease only (5-year survival 77%). On the contrary, a highly significant difference in survival (P < 0.001) was observed between these two groups of patients and those who had intraabdominal residual tumor. Twelve of 45 (26.6%) patients have recurred. FIGO stage, grade, and residual disease after primary surgery were determinant in predicting recurrence. Notably, no relation emerged between relapse rate and the node status at second-look. Copyright 1998 Academic Press.

Entities:  

Mesh:

Year:  1998        PMID: 9600823     DOI: 10.1006/gyno.1998.4964

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Obesity does not affect the number of retrieved lymph nodes and the rate of intraoperative complications in gynecologic cancers.

Authors:  Mehmet Coskun Salman; Alp Usubutun; Tulay Ozlu; Kubra Boynukalin; Kunter Yuce
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

Review 2.  The roles of second-look laparotomy and cancer antigen 125 in the management of ovarian carcinoma.

Authors:  A E Selman; L J Copeland
Journal:  Curr Oncol Rep       Date:  1999-09       Impact factor: 5.075

Review 3.  Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?

Authors:  Masashi Takano; Hiroshi Tsuda; Toru Sugiyama
Journal:  J Exp Clin Cancer Res       Date:  2012-06-01

4.  Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis.

Authors:  A Maggioni; P Benedetti Panici; T Dell'Anna; F Landoni; A Lissoni; A Pellegrino; R S Rossi; S Chiari; E Campagnutta; S Greggi; R Angioli; N Manci; M Calcagno; G Scambia; R Fossati; I Floriani; V Torri; R Grassi; C Mangioni
Journal:  Br J Cancer       Date:  2006-08-29       Impact factor: 7.640

5.  Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial.

Authors:  T Dell' Anna; M Signorelli; P Benedetti-Panici; A Maggioni; R Fossati; R Fruscio; R Milani; L Bocciolone; A Buda; C Mangioni; G Scambia; R Angioli; E Campagnutta; R Grassi; F Landoni
Journal:  Br J Cancer       Date:  2012-08-02       Impact factor: 7.640

6.  Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome.

Authors:  Francesco Legge; Marco Petrillo; Vincenzo Adamo; Salvatore Pisconti; Giovanni Scambia; Gabriella Ferrandina
Journal:  BMC Cancer       Date:  2008-12-12       Impact factor: 4.430

7.  The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients.

Authors:  J K Chan; R Urban; J M Hu; J Y Shin; A Husain; N N Teng; J S Berek; K Osann; D S Kapp
Journal:  Br J Cancer       Date:  2007-05-22       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.